JAMA Dermatology
-
healthAdult Hypopigmented Mycosis Fungoides Shows Low Progression Risk and Favorable Prognosis
A major US multicentre study confirms adult hypopigmented mycosis fungoides is indolent, with low progression rates and high response to skin-directed therapies.
-
healthGermany’s National Skin Cancer Screening Shows No Mortality Benefit
A comparative study reveals Germany’s nationwide melanoma screening program failed to reduce death rates compared to neighboring countries without population-based testing.
-
healthExpert Dermatologists Outperform AI Models in Real-World Skin Cancer Diagnosis
A major international study confirms expert dermatologists surpass AI accuracy in skin cancer detection, positioning algorithms as clinical support tools rather than specialist replacements.
-
healthAI Boosts Skin Condition Recognition but Lacks Actionable Guidance
New study reveals AI tools enhance consumer ability to identify skin concerns, yet fall short in providing clear next steps for treatment.
-
healthLutikizumab Shows Promise for Hidradenitis Suppurativa After Anti-TNF Failure
Phase 2 trial reveals lutikizumab improves outcomes in moderate-to-severe hidradenitis suppurativa patients unresponsive to anti-TNF therapy.